The FDA approved the 15-microgram-per-hour strength of Purdue Pharma's chronic pain patch Butrans, or buprenorphine. The drug, already approved in 20-microgram, 10-microgram and 5-microgram strengths, is indicated for moderate to severe chronic pain requiring a continuous opioid analgesic for an extended period.
New strength of Purdue Pharma's pain patch Butrans gets FDA OK
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|